Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Statistics in Biosciences|October 18, 2016
Bivariate Mixed Effects Analysis of Clustered Data with Large Cluster SizesDaowen Zhang, Jie Lena Sun, Karen Pieper
American Heart Journal|March 10, 2010
In-hospital management of patients with atrial flutterNancy M Allen LaPointe, Jie-Lena Sun, Sigal Kaplan
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 12, 2022
Recovery of left ventricular function is associated with improved outcomes in LVAD recipientsCameron Olsen, Aditya Mandawat, Jie-Lena Sun, et al.
The American Journal of Cardiology|April 9, 2008
Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospitalNancy M Allen Lapointe, Jie-Lena Sun, Sigal Kaplan, et al.
Journal of the American College of Cardiology|August 9, 2020
Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young AdultsMichel Zeitouni, Michael G Nanna, Jie-Lena Sun, et al.
Journal of the American College of Cardiology|February 21, 2004
The prognostic importance of comorbidity for mortality in patients with stable coronary artery diseaseMolly Sachdev, Jie Lena Sun, Anastasios A Tsiatis, et al.
Journal of the American College of Cardiology|October 7, 2004
Outcomes in heart failure patients after major noncardiac surgeryAdrian F Hernandez, David J Whellan, Sharon Stroud, et al.
The American Journal of Medicine|December 3, 2014
Venous thromboembolism and cardiovascular risk: results from the NAVIGATOR trialMarcelo Katz, Robert M Califf, Jie-Lena Sun, et al.
The American Journal of Cardiology|February 12, 2019
Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)Abhinav Sharma, Jie-Lena Sun, Yuliya Lokhnygina, et al.
American Heart Journal|April 30, 2017
Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trialAbhinav Sharma, Flávio de Souza Brito, Jie-Lena Sun, et al.
Pageof 9